HealthCor Management’s Neurocrine Biosciences NBIX Stock Holding History

HealthCor Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.39M	Sell	20,000 -1,720	-8%	-$205K	2.19%	8
2022 Q3	$2.31M	Buy	+21,720	New	+$2.31M	0.29%	49
2022 Q2	–	Sell	-23,480	Closed	-$2.2M	–	65
2022 Q1	$2.2M	Sell	23,480 -342,257	-94%	-$32.1M	0.15%	50
2021 Q4	$31.2M	Sell	365,737 -80,002	-18%	-$6.81M	1.7%	23
2021 Q3	$42.8M	Buy	445,739 +55,759	+14%	+$5.35M	1.84%	22
2021 Q2	$38M	Buy	+389,980	New	+$38M	1.52%	25
2021 Q1	–	Sell	-226,460	Closed	-$21.7M	–	93
2020 Q4	$21.7M	Sell	226,460 -700,610	-76%	-$67.2M	0.84%	34
2020 Q3	$89.1M	Buy	927,070 +571,300	+161%	+$54.9M	3.57%	15
2020 Q2	$43.4M	Sell	355,770 -1,191,970	-77%	-$145M	1.82%	26
2020 Q1	$134M	Buy	1,547,740 +740,876	+92%	+$64.1M	5.73%	5
2019 Q4	$86.7M	Sell	806,864 -686,616	-46%	-$73.8M	3.09%	12
2019 Q3	$135M	Sell	1,493,480 -877,910	-37%	-$79.1M	5.09%	2
2019 Q2	$200M	Buy	2,371,390 +855,300	+56%	+$72.2M	7.77%	1
2019 Q1	$134M	Buy	1,516,090 +747,460	+97%	+$65.9M	5.4%	5
2018 Q4	$54.9M	Buy	768,630 +358,274	+87%	+$25.6M	1.72%	22
2018 Q3	$50.5M	Sell	410,356 -383,599	-48%	-$47.2M	1.67%	26
2018 Q2	$78M	Buy	793,955 +102,360	+15%	+$10.1M	2.48%	15
2018 Q1	$57.4M	Sell	691,595 -833,405	-55%	-$69.1M	1.95%	18
2017 Q4	$118M	Sell	1,525,000 -562,110	-27%	-$43.6M	3.85%	11
2017 Q3	$128M	Sell	2,087,110 -463,068	-18%	-$28.4M	4.29%	5
2017 Q2	$117M	Buy	2,550,178 +1,325,178	+108%	+$61M	4.23%	7
2017 Q1	$53M	Buy	1,225,000 +236,100	+24%	+$10.2M	2.43%	13
2016 Q4	$38.3M	Buy	+988,900	New	+$38.3M	2.16%	18
2016 Q3	–	Sell	-450,000	Closed	-$20.5M	–	43
2016 Q2	$20.5M	Sell	450,000 -275,000	-38%	-$12.5M	1.12%	27
2016 Q1	$28.7M	Buy	+725,000	New	+$28.7M	1.62%	19
2015 Q4	–	Sell	-150,000	Closed	-$5.97M	–	47
2015 Q3	$5.97M	Buy	+150,000	New	+$5.97M	0.34%	33